Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
Journal of Medical Virology|October 20, 2012
Molecular epidemiology of recent HIV-1 infections in southern PolandJoanna Smoleń-Dzirba, Magdalena Rosińska, Piotr Kruszyński, et al.
Plos One|October 3, 2013
Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failureSara Lodi, Andrew Phillips, Sarah Fidler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2017
A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key PopulationsEsther Fearnhill, Annabelle Gourlay, Ruslan Malyuta, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virusJade Ghosn, Tatiana Bayan, Karolin Meixenberger, et al.
The Lancet. HIV|October 2, 2015
Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort studyNikos Pantazis, Kholoud Porter, Dominique Costagliola, et al.
Plos One|November 9, 2013
Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapyWolfgang Stöhr, Sarah Fidler, Myra McClure, et al.
Plos One|September 7, 2012
Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infectionElizabeth Hamlyn, Fiona M Ewings, Kholoud Porter, et al.
Antiviral Therapy|April 28, 2006
Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA loadDaniela Bezemer, Anthony de Ronde, Maria Prins, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2016
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV InfectionJohn Thornhill, Jamie Inshaw, Pontiano Kaleebu, et al.
AIDS (London, England)|November 7, 2015
Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?Inma Jarrin, Nikos Pantazis, Judith Dalmau, et al.
Pageof 15